Andrew Lakoff argues that a new 'pharmaceutical' way of thinking about and acting upon mental disorder is coming to reshape not only the field of psychiatry, but also our very notions of self. Drawing from a comprehensive ethnography of psychiatric practice in Argentina (a country which boasts the most psychoanalysts per capita in the world) Lakoff looks at new ways of understanding and intervening in human behaviour. He charts the globalization of pharmacology, particularily the global impact of US psychiatry and US models of illness, and further illustrates the clashes, conflicts, alliances and reformulations that take place when psychoanalytic and psychopharmacological models of illness and cure meet. Highlighting the social and political implications that these new forms of expertise about human behaviour and human thought bring, Lakoff presents an arresting case-study that will appeal to scholars and students alike.

The origins and development of the modern American emergency state From pandemic disease, to the disasters associated with global warming, to cyberattacks, today we face an increasing array of catastrophic threats. It is striking that, despite the diversity of these threats, experts and officials approach them in common terms: as future events that threaten to disrupt the vital, vulnerable systems upon which modern life depends. The Government of Emergency tells the story of how this now taken-for-granted way of understanding and managing emergencies arose. Amid the Great Depression, World War II, and the Cold War, an array of experts and officials working in obscure government offices developed a new understanding of the nation as a complex of vital, vulnerable systems. They invented technical and administrative devices to mitigate the nation's vulnerability, and organized a distinctive form of emergency government that would make it possible to prepare for and manage potentially catastrophic events. Through these conceptual and technical inventions, Stephen Collier and Andrew Lakoff argue, vulnerability was defined as a particular kind of problem, one that continues to structure the approach of experts, officials, and policymakers to future emergencies.

Some years-1789, 1929, 1989-change the world suddenly. Or do they? In 2020, a pandemic converged with an economic collapse, inequalities exploded, and institutions weakened. Yet these crises sprang not from new risks but from known dangers. The world-like many patients-met 2020 with a host of preexisting conditions, which together tilted the odds toward disaster. Perhaps 2020 wasn't the year the world changed; perhaps it was simply the moment the world finally understood its deadly diagnosis. In The Long Year, some of the world's most incisive thinkers excavate 2020's buried crises, revealing how they must be confronted in order to achieve a more equal future. Keeanga-Yamahtta Taylor calls for the defunding of police and the refunding of communities; Keisha Blain demonstrates why the battle against racism must be global; and Adam Tooze reveals that COVID-19 hit hardest where inequality was already greatest and welfare states weakest. Yarimar Bonilla, Xiaowei Wang, Simon Balto, Marcia Chatelain, Gautam Bhan, Ananya Roy, and others offer insights from the factory farms of China to the elite resorts of France, the meatpacking plants of the Midwest to the overcrowded hospitals of India. The definitive guide to these ongoing catastrophes, The Long Year shows that only by exposing the roots and ramifications of 2020 can another such breakdown be prevented. It is made possible through institutional partnerships with Public Books and the Social Science Research Council.

In recent years, new disease threats& mdash;such as SARS, avian flu, mad cow disease, and drug-resistant strains of malaria and tuberculosis& mdash;have garnered media attention and galvanized political response. Proposals for new approaches to "securing health" against these threats have come not only from public health and medicine but also from such fields as emergency management, national security, and global humanitarianism.

This volume provides a map of this complex and rapidly transforming terrain. The editors focus on how experts, public officials, and health practitioners work to define what it means to "secure health" through concrete practices such as global humanitarian logistics, pandemic preparedness measures, vaccination campaigns, and attempts to regulate potentially dangerous new biotechnologies.

As the contributions show, despite impressive activity in these areas, the field of "biosecurity interventions" remains unstable. Many basic questions are only beginning to be addressed: Who decides what counts as a biosecurity problem? Who is responsible for taking action, and how is the efficacy of a given intervention to be evaluated? It is crucial to address such questions today, when responses to new problems of health and security are still taking shape. In this context, this volume offers a form of critical and reflexive knowledge that examines how technical efforts to increase biosecurity relate to the political and ethical challenges of living with risk.

Some years-1789, 1929, 1989-change the world suddenly. Or do they? In 2020, a pandemic converged with an economic collapse, inequalities exploded, and institutions weakened. Yet these crises sprang not from new risks but from known dangers. The world-like many patients-met 2020 with a host of preexisting conditions, which together tilted the odds toward disaster. Perhaps 2020 wasn't the year the world changed; perhaps it was simply the moment the world finally understood its deadly diagnosis. In The Long Year, some of the world's most incisive thinkers excavate 2020's buried crises, revealing how they must be confronted in order to achieve a more equal future. Keeanga-Yamahtta Taylor calls for the defunding of police and the refunding of communities; Keisha Blain demonstrates why the battle against racism must be global; and Adam Tooze reveals that COVID-19 hit hardest where inequality was already greatest and welfare states weakest. Yarimar Bonilla, Xiaowei Wang, Simon Balto, Marcia Chatelain, Gautam Bhan, Ananya Roy, and others offer insights from the factory farms of China to the elite resorts of France, the meatpacking plants of the Midwest to the overcrowded hospitals of India. The definitive guide to these ongoing catastrophes, The Long Year shows that only by exposing the roots and ramifications of 2020 can another such breakdown be prevented. It is made possible through institutional partnerships with Public Books and the Social Science Research Council.

Government plays a critical role in mitigating individual and collective vulnerability to disaster. Through measures such as disaster relief, infrastructure development, and environmental regulation, public policy is central to making societies more resilient. However, the recent drive to replace public institutions with market mechanisms has challenged governmental efforts to manage collective risk. The contributors to this volume analyze the respective roles of the public and private sectors in the management of catastrophic risk, addressing questions such as: How should homeland security officials evaluate the risk posed by terrorist attacks and natural disasters? Are market-based interventions likely to mitigate our vulnerability to the effects of climate change? What is the appropriate relationship between non-governmental organizations and private security firms in responding to humanitarian emergencies? And how can philanthropic efforts to combat the AIDS crisis ensure ongoing access to life-saving drugs in the developing world? More generally, these essays point to the way thoughtful policy intervention can improve our capacity to withstand catastrophic events.

Additional Columbia / SSRC books on the Privatization of Risk and its Implications for Americans

"Bailouts: Public Money, Private Profit"Edited by Robert E. Wright

"Health at Risk: America's Ailing Health System-and How to Heal It"Edited by Jacob S. Hacker

"Laid Off, Laid Low: Political and Economic Consequences of Employment Insecurity"Edited by Katherine S. Newman

"Pensions, Social Security, and the Privatization of Risk"Edited by Mitchell A. Orenstein

The origins and development of the modern American emergency state From pandemic disease, to the disasters associated with global warming, to cyberattacks, today we face an increasing array of catastrophic threats. It is striking that, despite the diversity of these threats, experts and officials approach them in common terms: as future events that threaten to disrupt the vital, vulnerable systems upon which modern life depends. The Government of Emergency tells the story of how this now taken-for-granted way of understanding and managing emergencies arose. Amid the Great Depression, World War II, and the Cold War, an array of experts and officials working in obscure government offices developed a new understanding of the nation as a complex of vital, vulnerable systems. They invented technical and administrative devices to mitigate the nation's vulnerability, and organized a distinctive form of emergency government that would make it possible to prepare for and manage potentially catastrophic events. Through these conceptual and technical inventions, Stephen Collier and Andrew Lakoff argue, vulnerability was defined as a particular kind of problem, one that continues to structure the approach of experts, officials, and policymakers to future emergencies.

In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption.Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. Some essays show how individual and communal identities are affected by the marketing and availability of medications. Among these are an exploration of how the pharmaceutical industry shapes popular and expert understandings of mental illness in North America and Great Britain. There is also an examination of the agonizing choices facing Ugandan families trying to finance AIDS treatment. Several essays explore the inner workings of the emerging international pharmaceutical regime. One looks at the expanding quest for clinical research subjects; another at the entwining of science and business interests in the Argentine market for psychotropic medications. By bringing the moral calculations involved in the production and distribution of pharmaceuticals into stark relief, this collection charts urgent new territory for social scientific research. Contributors. Kalman Applbaum, Joao Biehl, Ranendra K. Das, Veena Das, David Healy, Arthur Kleinman, Betty Kyaddondo, Andrew Lakoff, Anne Lovell, Lotte Meinert, Adriana Petryna, Michael A. Whyte, Susan Reynolds Whyte

Andrew Lakoff argues that a new 'pharmaceutical' way of thinking about and acting upon mental disorder is coming to reshape not only the field of psychiatry, but also our very notions of self. Drawing from a comprehensive ethnography of psychiatric practice in Argentina (a country which boasts the most psychoanalysts per capita in the world) Lakoff looks at new ways of understanding and intervening in human behaviour. He charts the globalization of pharmacology, particularily the global impact of US psychiatry and US models of illness, and further illustrates the clashes, conflicts, alliances and reformulations that take place when psychoanalytic and psychopharmacological models of illness and cure meet. Highlighting the social and political implications that these new forms of expertise about human behaviour and human thought bring, Lakoff presents an arresting case-study that will appeal to scholars and students alike.

Recent years have witnessed an upsurge in global health emergencies-from SARS to pandemic influenza to Ebola to Zika. Each of these occurrences has sparked calls for improved health preparedness. This book addresses the question, how did we become "unprepared?" Emerging disease has only recently come to be understood as a problem of preparedness. Andrew Lakoff follows the history of health preparedness from its beginnings in 1960s Cold War civil defense to the early twenty-first century, when international health authorities carved out a global space for governing potential outbreaks. Alert systems and trigger devices now link health authorities, government officials, and vaccine manufacturers, all of whom manage the possibility of a global pandemic. Funds have been devoted to cutting-edge research on pathogenic organisms, and a system of post hoc diagnosis analyzes sites of failed preparedness to find new targets for improvement. Yet, despite all these developments, the project of global health security continues to be unsettled by the prospect of surprise.

This issue of Limn examines the concept of "Systemic Risk." It includes contributions from Stephen J. Collier, Andrew Lakoff, Martha Poon, Grahame Thompson, Douglas Holmes, Deborah Cowen, Christopher Kelty, Brian Lindseth, Onur Ozgode, Elizabeth Dunn, Myriam Dunn Cavelty, Benjamin Sims, Philip Bougen and Rebecca Lemov

Government plays a critical role in mitigating individual and collective vulnerability to disaster. Through measures such as disaster relief, infrastructure development, and environmental regulation, public policy is central to making societies more resilient. However, the recent drive to replace public institutions with market mechanisms has challenged governmental efforts to manage collective risk. The contributors to this volume analyze the respective roles of the public and private sectors in the management of catastrophic risk, addressing questions such as: How should homeland security officials evaluate the risk posed by terrorist attacks and natural disasters? Are market-based interventions likely to mitigate our vulnerability to the effects of climate change? What is the appropriate relationship between non-governmental organizations and private security firms in responding to humanitarian emergencies? And how can philanthropic efforts to combat the AIDS crisis ensure ongoing access to life-saving drugs in the developing world? More generally, these essays point to the way thoughtful policy intervention can improve our capacity to withstand catastrophic events.

Additional Columbia / SSRC books on the Privatization of Risk and its Implications for Americans

"Bailouts: Public Money, Private Profit"Edited by Robert E. Wright

"Health at Risk: America's Ailing Health System-and How to Heal It"Edited by Jacob S. Hacker

"Laid Off, Laid Low: Political and Economic Consequences of Employment Insecurity"Edited by Katherine S. Newman

"Pensions, Social Security, and the Privatization of Risk"Edited by Mitchell A. Orenstein

In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption.

Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. Some essays show how individual and communal identities are affected by the marketing and availability of medications. Among these are an exploration of how the pharmaceutical industry shapes popular and expert understandings of mental illness in North America and Great Britain. There is also an examination of the agonizing choices facing Ugandan families trying to finance AIDS treatment. Several essays explore the inner workings of the emerging international pharmaceutical regime. One looks at the expanding quest for clinical research subjects; another at the entwining of science and business interests in the Argentine market for psychotropic medications. By bringing the moral calculations involved in the production and distribution of pharmaceuticals into stark relief, this collection charts urgent new territory for social scientific research.

"Contributors." Kalman Applbaum, Joao Biehl, Ranendra K. Das, Veena Das, David Healy, Arthur Kleinman, Betty Kyaddondo, Andrew Lakoff, Anne Lovell, Lotte Meinert, Adriana Petryna, Michael A. Whyte, Susan Reynolds Whyte

Recent years have witnessed an upsurge in global health emergencies-from SARS to pandemic influenza to Ebola to Zika. Each of these occurrences has sparked calls for improved health preparedness. This book addresses the question, how did we become "unprepared?" Emerging disease has only recently come to be understood as a problem of preparedness. Andrew Lakoff follows the history of health preparedness from its beginnings in 1960s Cold War civil defense to the early twenty-first century, when international health authorities carved out a global space for governing potential outbreaks. Alert systems and trigger devices now link health authorities, government officials, and vaccine manufacturers, all of whom manage the possibility of a global pandemic. Funds have been devoted to cutting-edge research on pathogenic organisms, and a system of post hoc diagnosis analyzes sites of failed preparedness to find new targets for improvement. Yet, despite all these developments, the project of global health security continues to be unsettled by the prospect of surprise.